Low molecular weight heparin is associated with better outcomes than unfractionated heparin for thromboprophylaxis in hospitalized COVID-19 patients: a meta-analysis.

Mochamad Yusuf Alsagaff Eka Prasetya Budi Mulia Irma Maghfirah Yusuf Azmi Dita Aulia Rachmi Alqi Yutha Luqman Hakim Andira Bambang Pujo Semedi

Published in: European heart journal. Quality of care & clinical outcomes (2022)

Our meta-analysis showed that administration of LMWH was associated with better outcomes compared with UFH in hospitalized COVID-19 patients. Prospective cohorts and RCTs are urgently needed to explore the definitive effect of LMWH to provide direct high-certainty evidence. PROSPERO registration number: CRD42021271977.

Keyphrases

venous thromboembolism
systematic review
sars cov
growth factor
meta analyses
randomized controlled trial
type diabetes
weight loss